Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Nov. 02, 2024	Oct. 28, 2023
Operating activities
Net earnings	$ 810	$ 781
Adjustments to reconcile net earnings to total cash provided by operating activities:
Depreciation and amortization	650	702
Restructuring charges	4	(16)
Stock-based compensation	108	110
Gain on sale of subsidiary, net		(21)
Other, net	3	7
Changes in operating assets and liabilities:
Receivables	4	240
Merchandise inventories	(2,869)	(2,444)
Other assets	(16)	(17)
Accounts payable	2,483	1,468
Income taxes	(219)	(200)
Other liabilities	(397)	(320)
Total cash provided by operating activities	561	290
Investing activities
Additions to property and equipment	(528)	(612)
Net proceeds from sale of subsidiary		14
Other, net	6	(2)
Total cash used in investing activities	(522)	(600)
Financing activities
Repurchase of common stock	(285)	(270)
Dividends paid	(607)	(603)
Other, net		1
Total cash used in financing activities	(892)	(872)
Effect of exchange rate changes on cash and cash equivalents	(2)	(12)
Decrease in cash, cash equivalents and restricted cash	(855)	(1,194)
Cash, cash equivalents and restricted cash at beginning of period	1,793	2,253
Cash, cash equivalents and restricted cash at end of period	$ 938	$ 1,059